Close Menu

AMS Sling and Mesh Claims

Update 2023 – We are accepting AMS pelvic mesh removal and revision claims.

American Medical Systems (AMS)

AMS slings and mesh lawsuits are stayed during the pending bankruptcy of its parent company, Endo International, plc. Many women still have the implants indwelling and suffer complications. We are reviewing and accepting certain cases involving AMS products that required surgical revision or removal including:

  • SPARC Sling
  • Mini-Arc Sling
  • Monarc Sling
  • Apogee Pelvic Mesh
  • Elevate Pelvic Mesh
  • Perigee Pelvic Mesh

page11image3618000 page11image3618416 page11image3618624page11image3618832 page11image3619040

Transvaginal Mesh Verdicts

AMS has not had a jury trial and settled most of the cases of women injured by pelvic mesh products. It is important to note that other pelvic mesh manufacturers settled cases after juries rendered verdicts against the corporations. Verdicts and settlements follow, however, many of the verdicts are appealed by the losing party and settle for much lower amounts.

  1. 7/12: $5.5 million – Christine Scott – C.R. Bard Avaulta Plus – CA
  2. 2/13: $11.11 million – Linda Gross – Ethicon/JJ Prolift – NJ
  3. 8/13: $2 million – Donna Cisson – C.R. Bard Avaulta – MDL WV
  4. 2/14: $0 – Carolyn Lewis – Ethicon/JJ TVT-O – MDL WV
  5. 4/14: $1.2 million – Linda Batiste – Ethicon/JJ TVT-O – TX
  6. 7/14: $0 – Diane Albright – Boston Scientific Pinnacle – MA
  7. 8/14: $0 – Maria Cardenas – Boston Scientific Obtryx – MA
  8. 9/14: $3.27 million – Jo Huskey – Ethicon/JJ TVT-O – MDL WV
  9. 9/14: $73.465 million – Martha Salazar – Boston Scientific Obtryx – TX
  10. 11/14: $6.7+ million – Amal Eghnayem – Boston Scientific Pinnacle – MDL FL
  11. 11/14: $6.7+ million – Margarita Dotres – Boston Scientific Pinnacle – MDL FL
  12. 11/14: $6.7+ million – Mania Nunez – Boston Scientific Pinnacle – MDL FL
  13. 11/14: $6.5+ million – Juana Betancourt – Boston Scientific Pinnacle – MDL FL
  14. 11/14: $5.25 million – Jeanie Blankenship – Boston Scientific Obtryx – MDL WV
  15. 11/14: $4.75 million – Chris Wilson – Boston Scientific Obtryx – MDL
  16. 11/14: $4.25 million – Carol Campbell – Boston Scientific Obtryx – MDL
  17. 11/14: $4.25 million – Jacquelyn Tyree – Boston Scientific Obtryx – MDL
  18. 2/15: Settled – Wise v. Bard in the MDL
  19. 3/15: Settled – Bellew v. Ethicon (Prolift) in the MDL;
  20. 5/15: Settled – Sanchez v. Boston Scientific (Pinnacle) – CA
  21. 3/15: $5.7 million – Coleen Perry – Ethicon/JJ Abbrevo sling – CA
  22. 5/15: $100 million – Deborah Barda v. Boston Scientific Pinnacle and Advantage Fit – DL
  23. 10/15: $0 – Carol Cavness v. Ethicon/JJ Prosima – TX
  24. 10/15: $0 – Martha Carlson v. Boston Scientific Uphold – NC
  25. 12/15: $12.5 million – Hammons v. Ethicon/JJ (Prolift) – PA
  26. 2/16: $0 – Sherrer v. Boston Scientific Solyx and Bard Align – MO
  27. 2/16: $13.5 – Carlino v. Ethicon/JJ (TVT) – PA
  28. 4/17: $20.0 million – Engleman v. Ethicon/JJ (TVT Secur) – PA
  29. 5/17: $2.16 million – Betz v. Ethicon/Prolift – PA
  30. 9/17: $57.1 million – Ebaugh v. Ethicon/JJ (TVT-Secur) – PA
  31. 3/18: $35 million – Kaiser v. Ethicon/JJ (Prolift) – IN
  32. 4/18: $68 million – McGinnis v. Bard – NJ
  33. 1/19: $41 million – Emmett v. Ethicon/JJ – PA
  34. 4/19: $120 million – McFarland v. Ethicon/JJ – PA
  35. 5/19: $80+ million – Mesigian v. Ethicon/JJ – PA
  36. 6/19: $500,000 – Dunfee v. Ethicon/JJ (Prolift) – PA
  37. 3/22: 0 – McBroom v. Ethicon/JJ (Prolift, TVT-Secur) – AZ
  38. 3/22: 0 – Shears v. Ethicon/JJ (TVT) – WV
  39. 4/22: $2.5 million – Redding v. Coloplast (Novasilk) – FL
  40. 7/22: 0 – Burris v. Ethicon/JJ (Prolift, TVT-Secur) – OH
  41. 10/22: 0 – Jarrett v. Ethicon/JJ (TVT-O) – AR
  42. 10/22: 0 – Richards v. Ethicon/JJ (TVT-O) – TX
  43. 12/22: 0 – Snowden v. Ethicon/JJ (Abbrevo) – TX


On August 16, 2022, Endo International plc and certain of its subsidiaries, including Astora Women’s Health, LLC, purchaser of AMS in or around 2016, (collectively, “Endo”) initiated voluntary prearranged Chapter 11 proceedings in the U.S. Bankruptcy Court for the Southern District of New York. Due to these proceedings, an automatic stay of all legal proceedings against AMS and its parent companies was entered.

We have successfully prosecuted cases for women suffering with complications from their AMS transvaginal mesh products since 2011. For further in depth information, click the video link to review the medical legal animation in the podcast: Failed Transvaginal Mesh Injury Lawsuit Podcast. Claims include that the vaginal mesh devices are defective and cause serious health issues, including:

  • Vaginal mesh erosion: This is the most common complication following the use of surgical mesh devices to repair pelvic organ prolapse and stress urinary incontinence. Non-absorbable synthetic surgical mesh, such as that made of polypropylene or polyester, can break down or wear away over time. Part of the mesh may become exposed or protrude through the vagina.
  • Erosion of mesh into other organs: Less commonly, the mesh may erode into the urethra, bladder or rectum.
  • Vaginal mesh contraction: Shortening or tightening of the mesh over time can cause vaginal shortening, tightening or pain.
  • Pain during sexual intercourse
  • Urinary problems
  • Infections
  • Bleeding
  • Reoccurrence
  • Emotional issues
  • Chronic pain
  • Fistulas
  • Organ perforation
  • Incontinence
  • Pelvic nerve damage

Pelvic mesh and bladder sling problems have been reported by women for decades. Major medical clinics and university affiliated medical institutions, such as the Cleveland Clinic, have published articles and treatise on the  Mesh Problems and Complications

page1image1578272 page1image1584512 page1image1584928 page1image1583888 page1image1584304 page1image1580976 page1image1583472

American Medical Systems (AMS)

AMS pelvic mesh and bladder slings are no longer being sold on the medical market. Many women still have the implants indwelling. We are reviewing and accepting certain cases involving AMS products that required surgical revision or removal including:

  • SPARC Sling
  • Mini-Arc Sling
  • Monarc Sling
  • Apogee Pelvic Mesh
  • Elevate Pelvic Mesh
  • Perigee Pelvic Mesh

page11image3618000 page11image3618416 page11image3618624page11image3618832 page11image3619040

Deadlines Approaching

Contact us now for a free medical legal consultation about your pelvic mesh product at 1-800-814-4540. There are deadlines in each state and hospitals destroy medical records after a certain time period so contact us for a confidential consult now.

FDA Warnings You May Not Know About

July 2011: An FDA Safety Communication identified concerns and issued new recommendations about the use of surgical mesh for transvaginal repair of Pelvic Organ Prolapse (POP).

September 2011: FDA convened a public meeting of the Obstetrics and Gynecology Devices Panel to discuss the benefits and risks of this use. Subsequently, the FDA issued 131 orders to conduct post market surveillance studies (“522 orders”) to 34 manufacturers of surgical mesh for transvaginal repair of POP. Most manufacturers elected to stop marketing surgical meshfor transvaginal repair of POP after receiving their 522 orders.

January 2016: The FDA completed its reclassification of surgical mesh for transvaginal repair of POP into the highest risk class of devices (class III), which requires premarket approval (PMA) applications, the agency’s most stringent device review pathway, in order to stay on the market.

July 5, 2018: This was the deadline for applications to be filed for premarket approval for any surgical mesh marketed for transvaginal POP repair. Manufacturers that did not file PMAs by this deadline were required to withdraw their products from the market. Those that did file PMAs were allowed to keep their mesh products on the market while the FDA reviewed their PMAs.

February 12, 2019: The FDA convened an advisory committee meeting to share the available evidence and seek expert opinions on how to evaluate the risks and benefits of these devices. The committee evaluated mesh placed transvaginally in the anterior vaginal compartment, as well as identifying the appropriate patient population and physician training needed for these devices. Boston Scientific filed two PMAs for its devices, the Uphold LITE Vaginal Support System and the Xenform Soft Tissue Repair System. Coloplast filed a PMA for its device, Restorelle DirectFix Anterior.

In February 2019, the FDA convened an advisory panel of experts that recommended that to support a favorable benefit-risk profile, the effectiveness of surgical mesh for transvaginal repair of POP should be superior to native tissue repair at 36 months. The FDA agreed with these recommendations, and because such data were not provided by manufacturers in their PMAs, the FDA decided not to approve Pelvic Organ Prolapse devices. Even though these products can no longer be used in patients moving forward, Boston Scientific and Coloplast are required to continue follow up of the subjects already enrolled in their 522 studies.

In 2019, most of the AMS mesh products had been removed from the market and were no longer being implanted in women. However, thousands of women have the AMS products – Apogee, Perigee, Elevate and MiniArc, Sparc, Monarc Slings – implanted and are still indwelling. Many may experience complications and their surgeons may advise to have the implant surgically removed or revised.

Contact Us Now

Contact us for your free medical legal consultation at 1-800-814-4540 or email There are statutes of limitation that may bar your claim and medical record evidence is destroyed after a certain number of years, so contact us now

Share This Page:
Facebook Twitter LinkedIn